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We investigated the distribution of commensal staphylococcal 
species and determined the prevalence of multi-drug resistance 
in healthy cats and dogs. Risk factors associated with the 
carriage of multi-drug resistant strains were explored. Isolates 
from 256 dogs and 277 cats were identified at the species level 
using matrix-assisted laser desorption ionisation-time of flight 
mass spectrometry. The diversity of coagulase-negative 
Staphylococci (CNS) was high, with 22 species in dogs and 24 in 
cats. Multi-drug resistance was frequent (17%) and not always 
associated with the presence of the mecA gene. A stay in a 
veterinary clinic in the last year was associated with an 
increased risk of colonisation by multi-drug resistant 
Staphylococci (OR = 2.4, 95% CI: 1.1∼5.2, p value LRT = 0.04). 
When identifying efficient control strategies against antibiotic 
resistance, the presence of mechanisms other than methicillin 
resistance and the possible role of CNS in the spread of 
resistance determinants should be considered.
Keywords: antibiotics, coagulase-negative, matrix-assisted laser 
desorption ionisation-time of flight, staphylococci
Introduction
　Staphylococci resistant against methicillin and other 
antibiotics have frequently been reported in pets [5,27]. 
These microorganisms are opportunistic pathogens that 
may colonise the skin and mucosae of humans and other 
animals. Staphylococcus is currently divided into 
coagulase-positive and coagulase-negative species. The 
pathogenicity of coagulase-negative Staphylococci (CNS) 
has long been underestimated because they were associated 
with more chronic or subacute infections when compared to 
coagulase-positive Staphylococci (CPS) [20]. However, 
the etiological role of CNS in prosthesis and foreign body 
infections is increasingly being recognised in human 
medicine [12,13,23]. In pets, the pathogenic potential of 
these microorganisms has not yet been clearly recognized, 
although there have been some reports of infections related 
to methicillin-resistant CNS in cats and dogs [11,24].
　Few studies have addressed the composition of 
staphylococcal populations on the mucosae of healthy cats 
and dogs [8,9]. Previous investigations of the 
staphylococcal species diversity in these animals have 
focused on clinical isolates [34], mainly CPS [17], or 
described the distribution of well defined antibiotic 
resistance within a limited number of staphylococcal 
species [1,38]. However, these studies were carried out 
before 2005, when Staphylococcus (S.) pseudintermedius 
had not yet been described. In fact, this species had 
probably been reported in all previous studies as S. 
intermedius, leading to confusion regarding its actual 
occurrence in pets [14,21,22,29,30]. S. pseudintermedius 
has recently been suggested as the most relevant and 
prevalent CPS dog coloniser, and there have been 
increasing reports on its pathogenicity and methicillin 
resistance [15].
　To date, CNS strains in pets has been neglected; however, 
the recent development of new molecular techniques has 
allowed accurate identification of CNS [3,31], which will 
eventually lead to a better understanding of these bacterial 
species. Additional knowledge regarding CNS carriage in 
animals will be of benefit, because these bacteria might 
represent a pool of antibiotic resistance for CPS species. 
Indeed, horizontal gene transfer of staphylococcal 
chromosome cassette mec (SCCmec) between CPS and 
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CNS species has been documented [19].
　In the last decade, several authors have suggested that 
pets may be reservoirs of antibiotic resistant bacteria 
[18,25,26]. This assumption was mainly based on studies 
reporting antibiotic resistance in clinical CPS isolates from 
dogs and humans in close contact [28,37]. However, a clear 
picture of the distribution, diversity and multi-drug 
resistance of both CPS and CNS species in pets is lacking, 
as is the role of cats and dogs as reservoirs of antibiotic 
resistance.
　The purpose of the present study was to gain insight into 
the distribution of commensal staphylococcal species of 
healthy cats and dogs and determine the occurrence of 
multi-drug resistance in both CNS and CPS. We also 
explored risk factors associated with the carriage of these 
microorganisms by pets.
Materials and Methods
Study design and settings
　Samples were collected between March 2008 and 
December 2009 from four different Swiss cantons (Berne, 
Ticino, Vaud and Zurich). Only healthy pets with no overt 
acute disease at the time of sample collection were enrolled 
in the study. The pets either lived in or visited nursing 
homes for pet-therapy or lived in households. The selection 
strategy differed between community and nursing homes. 
Pets in the community were included in the study based on 
convenience sampling in households (n = 196) in four 
Swiss cantons representing the northern, southern, central 
and western part of Switzerland. Additional pets (n = 239) 
were recruited from cats and dogs visiting a total of 12 
veterinary practices in the same regions for routine 
vaccinations. Nursing homes were selected by two-stage 
random cluster sampling from an exhaustive list of nursing 
homes located in the four Swiss cantons as reported in [16]. 
In randomly selected nursing homes, all pets matching the 
inclusion criteria and present at the time of sample 
collection (n = 98) were enrolled in the study. Informed 
written consent was obtained from all pet owners prior to 
the start of the study, and the investigation received the 
approval for animal experimentation from the Cantonal and 
Swiss Federal Veterinary Offices (authorisation reference 
No. 01/2008-02/2008).
Sample collection
　Nasal and ear swab samples were collected using cotton 
swabs (Amies agar gel 108C and 110C; Copan, Italy) that 
had been soaked in a physiological 9% NaCl solution. For 
collection, a swab was introduced 1∼2 cm in the nostril, 
while a second swab was introduced as deeply as possible in 
the ear channel of each animal. The collected samples were 
then stored in transport medium at room temperature and 
analyzed for the presence of Staphylococci within 24∼48 h 
of collection. A questionnaire collecting information 
regarding the demographic and health status of the pets was 
filled in by the owners (available on request).
Sample analyses
　Both swabs were streaked onto Mannitol Salt Agar 
(Chapman 2 - MSA 2; bioMérieux, France), after which 
they were incubated for 48 h at 37oC, enriched in MRSA 
broth supplemented with 6 μg of oxacilllin (48 h at 37oC) 
and cultured on Gelose ChromID S. aureus (SAID; 
bioMérieux) for 48 h at 37oC. All morphologically 
different colonies were isolated and catalase positive, 
Gram positive coccal bacteria were frozen in skim milk at 
−80oC until further analyses.
　Isolates were grown on blood agar for 24 h and then 
identified by matrix-assisted laser desorption ionisation- 
time of flight mass spectrometry (MALDI-TOF MS) using 
an Axima Confidence spectrometer (Shimadzu-Biotech, 
Japan) in positive linear mode (m/z = 2,000 to 20,000) [10]. 
The identity of isolates that could not be identified by 
MALDI-TOF MS (24%) was confirmed by sequencing of 
the amplified partial rpoB gene [31].
　Phenotypic antibiotic resistance to 24 different drugs was 
assessed by the Kirby-Bauer method on Mueller-Hinton 
blood agar (MHS2; bioMérieux). The following antibiotics 
were tested: penicillin (10 units), ampicillin (10 μg), 
oxacillin (1 μg), cefazolin (30 μg), gentamicin (10 μg), 
tetracycline (30 μg), erythromycin (15 μg), clindamycin (2 
μg), vancomycin (30 μg), trimethoprim-sulfamethoxazole 
(1.25 + 23.75 μg), ciprofloxacin (5 μg), amoxicillin and 
clavulanic acid (20 + 10 μg), ceftazidim (30 μg), imipenem 
(10 μg), tobramycin (10 μg), fusidic acid (10 μg), 
rifampicin (30 μg), chloramphenicol (30 μg), cefoxitin (30 
μg), kanamycin (30 μg), doxycyclin (30 μg), mupirocin (5 
μg), linezolid (30 μg) and quinopristin-dalfopristin (15 μg). 
An inducible clindamycin resistance test (“D-zone” test) 
was also carried out for all isolates. Results were interpreted 
according to the Clinical and Laboratory Standards 
Institute (CLSI) guidelines [4,32], and intermediate results 
were classified as resistant. Multi-drug resistance (MDR) 
was defined as resistance to at least three drugs belonging to 
three different antibiotic classes [16]. Additionally, the 
presence of the mecA gene, which confers methicillin 
resistance, was investigated by polymerase chain reaction 
(PCR) on all isolates that showed phenotypic resistance to 
oxacillin [6,7]. We considered isolates from the same 
animal as being different strains if they belonged to 
different staphylococcal species or their phenotypic 
antibiotic resistance profiles differed.
Statistical analyses
　Sample size calculation was based on the assumption that 
5% of pets carried at least one MDR staphylococcal strain 
and that the intra-class correlation coefficient (rho) in these 
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Table 1. Demographics of investigated cats and dogs 
Characteristics
Nursing home (N = 98) Community (N = 435)
n/N %* 95% CI n/N %* 95% CI 
Cats
Female
Sterilized
Age
　＜ 3 years 
　3∼10 years 
　＞10 years
Cantons
　Berne
　Ticino
　Vaud
　Zurich
Visited veterinary clinics in the last year
Stayed in an animal home in the last year
Pyoderma in the last year
Urinary infections in the last year
Otitis in the last year
Antibiotic treatment in the last 3 months
Immunosuppressant treatment in the last 3 months
53/98
63/98
80/98
19/98
56/98
23/98
32/98
26/98
20/98
20/98
3/97
8/98
3/96
4/93
3/93
5/94
3/92
54
64
82
19
57
23
33
27
20
20
3
8
3
4
3
5
3
44∼63
54∼73
73∼88
12∼27
47∼67
15∼32
23∼42
18∼35
12∼28
12∼28
1∼9
4∼15
1∼9
2∼11
1∼10
2∼12
1∼10
224/435
226/434
306/433
156/435
189/435
90/435
95/435
140/435
107/435
93/435
28/431
22/434
22/423
17/421
39/425
59/429
20/423
51
52
71
36
43
21
22
32
25
21
7
5
5
4
9
14
5
47∼56
47∼57
66∼75
31∼40
39∼48
17∼24
18∼26
28∼37
21∼29
18∼25
5∼9
3∼8
3∼8
3∼6
7∼12
11∼17
3∼7
*Proportions. CI: confidence interval.
Table 2. Proportion of staphylococcal and MDR staphylococcal carriage in cats and dogs
Staphylococcal carriage
Multi-drug resistance carriage
Staphylococci CPS CNS CPS & CNS
n/N %* 95% CI n/N %* 95% CI n/N n/N n/N
Total
Cats
Dogs
320/533
164/277
156/256
60.0
59.2
60.9
55.8∼64.1
53.3∼64.8
54.8∼66.7
92/533
41/277
51/256
17.3
14.8
20.0
14.3∼20.7
11.0∼19.5
15.5∼25.4
21/92
1/41
20/51
67/92
39/41
28/51
4/92
1/41
3/51
*Proportions. CPS: coagulase-positive staphylococci, CNS: coagulase-negative staphylococci. 
settings was 0.15. We used the cluster sample equation 
developed by Bennett et al. [2] for all sample size 
calculations. Assuming that each nursing home with pets 
owned or was visited by three animals on average, sample 
collection in 42 different nursing homes would have 
provided 126 pets. Accordingly, the expected precision for 
the prevalence estimate of MDR in pets would have a 
standard error of 2.2%, and a 95% confidence interval (CI) 
= 0.68∼9.3%.
　The characteristics of the cats and dogs were compared to 
check for consistent differences in the demographics and 
health status of the different populations sampled. A 
Chi-square test (Fisher’s exact test when expected 
observations ＜ 5) and 95% CI were used for this 
comparison. We reported the prevalence of Staphylococci 
and MDR Staphylococci and the distribution of antibiotic 
resistance among different staphylococcal species together 
with the median number of resistances to different 
antibiotic classes. Univariable logistic regression models 
with MDR staphylococcal carriage status of the pet as the 
outcome variable of interest were applied to explore risk 
factors. Unadjusted odds ratios (OR with 95% CI) were 
calculated as a measure of association. Statistical 
significance of each explanatory variable was determined 
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Table 3. Staphylococci in nostrils and ears of dogs (N = 256) and cats (N = 277) and their antibiotic resistance profiles
Identified isolates
Dogs Cats
MDR isolates* Max. AB† mecA‡ MDR isolates* Max. AB† mecA‡
Nostril Ear Nostril Ear Nostril Ear Nostril Ear Nostril Ear Nostril Ear
Coagulase positive
　S. aureus
　S. pseudintermedius
Coagulase negative
　S. arlettae
　S. auricularis
　S. capitis
　S. caprae
　S. caprae/capitis
　S. cohnii
　S. devriesei
　S. epidermidis
　S. equorum
　S. felis
　S. haemolyticus
　S. hominis
　S. kloosi
　S. lentus
　S. lugdunensis
　S. nepalensis
　S. pasteuri
　S. pettenkoferi
　S. saprophyticus
　S. sciuri
　S. simulans
　S. succinus
　S. vitulinus
　S. warneri
　S. xylosus
Other staphylococci
　S. schleiferi subsp.
　Staphylococcus spp.
15/69
0/10
15/59
22/97
1/1
0/1
0/3
–
0/5
2/4
–
2/15
2/9
–
2/8
2/9
–
–
–
–
0/2
0/2
0/4
6/6
0/1
0/3
0/6
2/9
3/9
–
2/10
9/29
0/3
9/26
14/75
–
0/1
0/1
–
0/3
0/1
0/3
1/12
0/3
–
2/5
1/11
0/1
1/1
0/1
–
0/1
–
1/5
1/1
–
0/1
0/2
5/13
2/9
–
0/4
6
2
6
8
3
0
0
–
2
5
–
7
4
–
8
3
–
–
–
–
1
0
2
4
1
2
1
3
4
–
3
6
2
6
8
-
0
0
–
1
1
0
3
0
–
8
3
1
3
0
–
1
–
3
4
–
0
1
5
4
–
1
0/69
0/10
0/59
8/97
0/1
0/1
0/3
–
0/5
0/4
–
2/15
1/9
–
2/8
2/9
–
–
–
–
0/2
0/2
0/4
1/6
0/1
0/3
0/6
0/9
0/9
–
0/10
0/29
0/3
0/26
3/75
–
0/1
0/1
–
0/3
0/1
0/3
1/12
0/3
–
0/5
1/11
0/1
0/1
0/1
–
0/1
–
0/5
0/1
–
0/1
0/2
1/13
0/9
–
0/4
0/17
0/11
0/6
23/132
1/1
0/4
1/1
–
0/4
0/2
–
5/16
1/11
4/41
2/5
1/5
–
1/3
–
1/2
–
0/4
0/2
2/5
0/3
–
0/1
1/12
3/10
0/1
0/3
2/5
0/3
2/2
19/126
–
1/10
1/6
0/1
0/5
1/3
–
4/20
0/10
2/28
0/1
0/4
–
1/1
1/2
–
0/1
0/4
1/4
1/3
1/8
0/1
–
2/6
3/8
0/1
1/15
1
1
0
7
6
0
3
–
2
1
–
4
7
3
3
5
–
4
–
4
–
0
2
3
2
–
1
4
4
0
2
5
1
5
7
–
4
3
1
1
4
–
7
2
3
1
1
–
3
3
–
2
0
3
3
3
0
–
4
3
0
4
0/17
0/11
0/6
3/132
0/1
0/4
0/1
–
0/4
0/2
–
1/16
0/11
0/41
0/5
1/5
–
0/3
–
0/2
–
0/4
0/2
1/5
0/3
–
0/1
0/12
0/10
0/1
0/3
0/5
0/3
0/2
4/126
–
0/10
0/6
0/1
0/5
0/3
–
4/20
0/10
0/28
0/1
0/4
–
0/1
0/2
–
0/1
0/4
0/4
0/3
0/8
0/1
–
0/6
0/8
0/1
0/15
*Number of multi-drug resistant isolates over the total number of isolates for a given species or group. †Maximum number of different resistant antibiotic 
classes. ‡Number of strains carrying the gene encoding methicillin resistance over the total number of isolates for a given species or group.
by a likelihood-ratio test (LRT). We included in a 
multivariable model all variables with LRT p values ≤ 0.2 
from the univariable analysis. All statistical analyses were 
performed using STATA 9.0 (Stata Corporation, USA).
Results
Demographics and staphylococcal carriage in pets
　We collected samples from 533 healthy pets (277 cats and 
256 dogs), 98 of which lived in or visited nursing homes at 
least once a week and 435 that lived in the community. The 
demographics of the two populations studied are reported 
in Table 1. Parameters such as sex, age, sterilisation, otitis 
in the last year, and antibiotic treatment showed different 
distributions between the nursing home and community 
settings, but the 95% CI estimates of these parameters 
overlapped (Table 1). We did not carry out stratified 
analyses of the samples because the overall frequencies of 
MDR in nursing homes (15/98) and in the community 
(76/435) did not differ significantly (χ2 = 0.27, p = 0.6). 
　Staphylococci were detected in 60% (320/533) of pets, 
and 17% (92/533) of all animals carried at least one MDR 
strain. There were no significant differences in MDR 
carriage between pet species [14.8% (95% CI: 11.0∼19.5) 
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Table 4. In vitro antibiotic resistance of the isolates investigated
Isolates from dogs
(N = 284)
Isolates from cats 
(N = 300)
n (%) n (%)
Penicillin
Ampicillin
Oxacillin
Ceftazidim
Cefoxitin
Cefazolin
Co-amoxicillin
Imipenem
Kanamycin
Gentamicin
Tobramycin
Tetracycline
Doxycyclin
Erythromycin
Clindamycin
Vancomycin
Ciprofloxacin
Trimethoprim-
  sulfamethoxazole
Rifampicin
Chloramphenicol
Linezolid
Quinopristin-
  dalfopristin
Fusidic acid
Mupirocin
140 (49)
131 (46)
13 (5)
13 (5)
9 (3)
1 (0.3)
1 (0.3)
0
31 (11)
5 (2)
1 (0.3)
44 (15)
35 (12)
72 (25)
45 (16)
0
4 (1)
10 (3)
0
22 (8)
0
8 (3)
87 (31)
0
90 (30)
77 (26)
7 (2)
8 (3)
7 (2)
0
1 (0.3)
0
4 (1)
1 (0.3)
0
17 (6)
12 (4)
58 (19)
39 (15)
0
5 (2)
4 (1)
0
4 (1)
0
10 (3)
85 (28)
1 (0.3)
in cats and 20.0% (95% CI: 15.5∼25.4) in dogs; χ2 = 2.1, 
p = 0.14] (Table 2). In cats, most CNS were MDR (39/41), 
whereas the proportion of MDR in CPS was small (1/41). 
Conversely, MDR CPS (20/51) and MDR CNS (28/51) 
carriage was almost equal in dogs (Table 2). Additionally, 
we observed species-specific differences (χ2 = 63.69, p ＜ 
0.001) in the proportion of S. pseudintermedius carriage, 
with 27% (70/256) of dogs and 3% of cats (8/277) 
harbouring this species. No difference in S. aureus carriage 
was observed between the two pet species (13/256 dogs 
and 14/277 cats, respectively).
Staphylococcal isolates
　We isolated 284 staphylococcal strains (176 from the 
nostrils and 108 from the ears) from dogs and 300 (153 
from the nostrils and 147 from the ears) from cats (Table 3). 
We were able to identify 94.5% (552/584) of all isolates at 
the species level. Two S. schleiferi isolates from two cats 
were identified only at the species level. CNS species 
accounted for 60% (172/284) of all isolates in dogs and 
86% (258/300) in cats (Table 3).
　In cats, the total number of CPS strains was lower 
(22/300) than in dogs (98/284). Among the CPS strains, S. 
pseudintermedius was more frequently isolated from dogs 
[(85/98), 87%] than from cats [(8/22), 36%], whereas S. 
aureus was more frequent in cats [(14/22), 63%] than dogs 
[(13/98), 13%]. No other CPS were isolated. 
　The diversity of CNS was high, with 22 different species 
in dogs and 24 in cats (Table 3). S. felis was only isolated 
from cats, in particular from their nostrils, and it 
represented 31% of all CNS isolates (41/132). Other CNS 
recovered in relevant proportions from both pets were S. 
epidermidis, S. warneri, S. hominis, S. xylosus and S. 
equorum (Table 3).
Antibiotic resistance
　The mecA gene was present in 6% (11/172) of dog and 3% 
(7/258) of cat isolates. We did not recover any MDR S. 
aureus (Table 3). MDR, with a few strains showing 
resistance to eight different antibiotic classes, was detected 
in bacteria at proportions of 21% (36/172) in dogs and 16% 
(42/258) in cats. MDR was observed in S. pseudintermedius 
isolated from both pet species with resistance to up to six 
different antibiotic classes, but no methicillin resistance was 
seen (Table 3).
　About 50% of all isolates in dogs and 30% in cats showed 
phenotypic resistance to penicillin and ampicillin (Table 4). 
Fusidic acid and erythromycin resistance were detected in 
31% and 25% of dog and 28% and 19% of cat isolates, 
respectively. Additionally, 15% of all strains isolated from 
dogs were resistant to tetracycline and 11% to kanamycin. 
Clindamycin resistance was reported from 16% of dog and 
15% of cat isolates (Table 4). 
Exploratory analysis of risk factors
　Univariable exploratory analysis revealed that a stay in a 
veterinary clinic in the last year was associated with 
increased risk of colonisation by MDR Staphylococci (OR 
= 2.4, 95% CI: 1.1∼5.2, p value LRT = 0.04; Table 5). We 
included species, canton, stay in veterinary clinic in the last 
year, and antibiotic treatment in the last 3 months in the 
multivariable analysis. No missing data for these variables 
was observed for all 465 records. When accounting for 
other variables, we observed an influence of the cantons 
(geographic origin) on the carriage of MDR Staphylococci 
(p value LRT = 0.02). Additionally, cats had a lower risk of 
being carriers of MDR Staphylococci, whereas a stay in a 
veterinary clinic in the last year and antibiotic treatment in 
the last 3 months were associated with a higher risk, 
although these differences were not statistically significant 
(Table 5).
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Table 5. Risk factors for cats and dogs to be carriers of MDR Staphylococci 
Variable level MDR
Univariable analysis Multivariable model
OR LRT OR† LRT
N n (%) 95% CI p value* 95% CI p value*
Origin
　Nursing homes
　Community setting
Species
　Dog
　Cat
Sex
　Male
　Female
Age 
　0∼3 years
　3∼10 years
　10∼20 years
Sterilised
　No
　Yes
Canton
　Bern
　Ticino
　Vaud
　Zurich
Stayed in veterinary clinic in the last year
　No
　Yes
Stayed in animal home in the last year
　No
　Yes
Pyoderma in the last year
　No
　Yes
Urinary infection in the last year
　No
　Yes
Otitis in the last year
　No
　Yes
Antibiotic treatment in the last 3 months
　No
　Yes
Immunosuppressant in the last 3 months
　No
　Yes
98
434
255
277
243
288
175
245
112
145
385
126
166
127
113
496
31
501
30
493
25
492
21
475
42
458
64
491
23
15 (15)
76 (18)
50 (20)
41 (15)
42 (17)
49 (17)
36 (21)
40 (16)
15 (13)
27 (19)
64 (17)
20 (16)
20 (12)
27 (21)
24 (21)
81 (16)
10 (32)
84 (17)
7 (23)
85 (17)
5 (20)
88 (18)
2 (10)
84 (18)
7 (17)
73 (16)
15 (23)
79 (16)
6 (26)
Baseline
　1.1
Baseline
　0.7
Baseline
　1.0
Baseline
　0.8
　0.6
Baseline
　0.9
Baseline
　0.7
　1.4
　1.4
Baseline
　2.4
Baseline
　1.5
Baseline
　1.2
Baseline
　0.5
Baseline
　0.9
Baseline
　1.6
Baseline
　1.8
0.6∼2.0
0.4∼1.1
0.6∼1.5
0.5∼1.2
0.3∼1.2
0.5∼1.4
0.4∼1.4
0.8∼2.7
0.7∼2.8
1.1∼5.4
0.6∼3.6
0.4∼3.3
0.1∼2.1
0.4∼2.2
0.9∼3.0
0.7∼4.8
0.6
0.1
0.9
0.3
0.6
0.1
0.04
0.4
0.7
0.3
0.9
0.1
0.24
Not included
Baseline
　0.7
Not included
Not included
Not included
Baseline
　0.6
　1.5
　1.5
Baseline
　1.3
Not included
Not included
Not included
Not included
Baseline
　1.3
Not included
0.4∼1.1
0.3∼1.2
0.8∼3.0
0.8∼3.0
0.4∼3.8
0.6∼2.8
0.1
0.02
0.6
0.4
*p value considered statistically significant if  ≤ 0.05. MDR: multi-drug resistance, OR: odds ratio, LRT: likelihood-ratio test.
Discussion 
　This study provides detailed information on 
staphylococcal carriage in healthy cats and dogs and on 
drug resistance of these bacteria to different antibiotic 
classes for the first time since the description of S. 
pseudintermedius. We showed that S. pseudintermedius 
was recovered from the mucosae of healthy dogs more 
frequently than from those of healthy cats. Previous 
hospitalisation (at least one night in a veterinary clinic) was 
a risk factor for the carriage of MDR Staphylococci in pets 
using the univariable approach. The multivariable model 
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showed that geographical distribution of the animals in the 
four cantons had an influence on the carriage of MDR 
staphylococci, which might reflect different pet health care 
and prescription practices of veterinarians in different 
regions of Switzerland. 
　Identification of the Staphylococci was carried out by 
MALDI-TOF MS, which provides reliable and rapid 
identification of the taxa in the S. intermedius group (S. 
delphini, S. intermedius and S. pseudintermedius) [10]. 
Previous investigations of the staphylococcal population 
of the mucosae of cats and dogs were based on phenotypic 
characterisation of the isolates, which may have led to 
misidentification of some closely related staphylococcal 
species [22,39]. 
　We isolated MDR staphylococcal strains from healthy cats 
and dogs; however, MDR was not always associated with 
the presence of the mecA gene. In this study, resistance of 
strains to different antibiotic classes ranged from very low 
proportions (e.g., 1∼2% resistance to ciprofloxacin in cats 
and dogs) to high values (11%) for kanamycin resistance in 
dogs. Methicillin resistance is of particular interest, because 
it confers resistance to all beta-lactams and is also often 
linked to resistance to other antibiotic classes; however, 
other resistances are also relevant in clinical settings, and 
infections resulting from MDR opportunistic pathogens are 
a critical problem to clinicians because they limit the choice 
of active antibiotic treatments [36].
　It should be noted that our study has some limitations. 
Specifically, the exploratory analysis of risk factors was 
carried out by combining all staphylococcal species and 
information on pet-therapy animals as well as household 
pets, even though the risk associated with the carriage of 
MDR Staphylococci belonging to several species might 
differ between groups. This approach was necessary 
because the numbers for given combinations of investigated 
risk factors and animals carrying different MDR 
staphylococcal species were small. Pet management factors 
in the three months preceding the study were reported by the 
owners; therefore, a recall bias might be present. However, 
we do not consider this potential bias to be important 
because one can reasonably expect pet owners to recall 
whether or not a pet had visited a veterinary clinic during the 
preceding three months. We did not collect data on the 
number of different antibiotic treatments and the length of 
treatments, and the analysis of these data might have 
revealed other risk factors. In addition, we defined MDR as 
resistance of a strain to at least three antibiotics of different 
classes. Official guidelines (e.g., CLSI and EUCAST) lack 
a clear and standard criteria to define a staphylococcal strain 
as MDR, which reduces the possibility of carrying out 
meaningful comparisons with published data [16]. Despite 
the limitations of an exploratory univariable approach, our 
results confirm findings from published studies regarding 
factors associated with the carriage of MDR Staphylococci 
in pets, and in particular, the importance of previous 
hospitalisation, which was already reported as a risk factor 
for acquisition of both MRSA and MRSP in pets [33,35]. 
　Our study has shown that carriage of multi-drug resistant 
Staphylococci in healthy cats and dogs is common; thus, 
clinical therapy guidelines would benefit from an approach 
that is not only focused on methicillin resistance, 
neglecting the presence of other resistances. The 
monitoring of antibiotics use in veterinary clinics could 
provide an overview of possible future trends of antibiotic 
resistance in pets. In veterinary medicine, further studies 
investigating the dissemination of antibiotic resistance 
determinants would benefit from considering the possible 
role of reservoirs of CNS in their spread.
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